Fluorobiotech was honored to present at the Global Partners Meeting of the WHO / Medicines Patent Pool (MPP) mRNA Vaccine Technology Transfer Program, a landmark event that brought together manufacturers, policymakers, and researchers from over 15 countries committed to building mRNA vaccine manufacturing capacity in low- and middle-income countries (LMICs)....
Fluorobiotech Takes the African Tech Stage at VivaTech 2025 in Paris
Fluorobiotech proudly represented African innovation on the global stage as Chief Operating Officer, Dr. Ross Rayne Vermeulen delivered a pitch at VivaTech 2025, one of the world’s leading events for technology and innovation. Selected to present on the African Tech Stage, Vermeulen shared Fluorobiotech’s ambitious mission to transform Africa into...